Darbelife 200 Injection (Darbepoetin Alfa Injection 200 mcg)

Darbelife 200 Injection is a branded biopharmaceutical product containing darbepoetin alfa, a long-acting erythropoiesis-stimulating agent (ESA). Supplied as a single-dose prefilled syringe, Darbelife 200 Injection is developed for regulated pharmaceutical distribution and professional healthcare use. AmeriDrugs supplies this product exclusively for export to licensed importers, distributors, hospitals, and pharmacies across regulated international markets.

Active Ingredient (API + Strength)

• Active Pharmaceutical Ingredient: Darbepoetin Alfa

• Strength: 200 mcg per 0.40 ml

• Dosage Form: Sterile solution in prefilled syringe

Therapeutic Use (Informational, Non-Advisory)
Darbepoetin alfa is a recombinant erythropoietin analog used within approved clinical frameworks to support erythropoiesis in specific medical conditions. Darbelife 200 Injection is supplied for use in accordance with locally approved treatment protocols and regulatory guidelines. This content is provided strictly for product identification and informational purposes and does not constitute medical advice or therapeutic recommendations.

Dosage Form & Route of Administration

• Dosage Form: Prefilled syringe containing sterile injectable solution

• Routes of Administration: Subcutaneous or intravenous (as per approved local protocols)

• Prescription Status: Prescription-only medicine

• Intended for professional handling within regulated pharmaceutical channels

Quality & Manufacturing Standards
Darbelife 200 Injection is manufactured in compliance with current Good Manufacturing Practices (GMP) and applicable biopharmaceutical quality standards. Production processes include validated controls to ensure sterility, protein stability, and batch consistency. Each batch undergoes comprehensive quality testing aligned with export and regulatory requirements.

Packaging Information (Export-Oriented)

• Primary Packaging: Single-dose prefilled syringe (0.40 ml)

• Secondary Packaging: Printed carton with regulatory-compliant labeling

• Packaging suitable for temperature-controlled international logistics

• Export documentation and labeling customization supported based on destination market regulations

Target Buyers

• Licensed pharmaceutical importers and distributors

• Hospital pharmacies and institutional healthcare providers

• Retail and wholesale pharmacies operating under prescription regulations

• Government and private healthcare procurement organizations

• International distributors specializing in injectable biologics

Regulatory & Compliance Note
Darbelife 200 Injection is a prescription-only biological medicine intended for regulated pharmaceutical distribution. Not for direct consumer self-use. Supply is subject to import authorization, local drug regulatory approvals, and applicable compliance requirements in the destination country. AmeriDrugs follows international export compliance standards and supports regulated market documentation.